Trial NCT01120275

View at ClinicalTrials.gov 
Org. Study IDs: NCI-2011-02040
Secondary IDs: CDR0000671815 NCI-2011-02040 S0933 SWOG-S0933 U10CA032102

Last trial update was posted on 2016-06-14

MeSH Interventions

2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide

MeSH Conditions

Hutchinson's Melanotic Freckle Lentigo Melanoma

Other Conditions

Acral Lentiginous Malignant Melanoma Lentigo Maligna Malignant Melanoma Nodular Malignant Melanoma Recurrent Melanoma Solar Radiation-related Skin Melanoma Stage IV Melanoma Superficial Spreading Malignant Melanoma

Stopping Reasons

Administratively complete.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID